It affects 16% of people in the United States. The accompanying systematic review of prophylactic migraine medication effectiveness, led by Johanna A. A. Damen, PhD, an assistant professor in the ...

mgh.harvard.edu We read with interest the article ‘Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm ...